Vimarsana
Biggest News Aggregation in the World

Page 6 - Epic Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Epic Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Epic Pharma Today - Breaking & Trending Today

Epic Pharma Automates for Difficult-to-Convey Powder - Vimarsana News

Epic Pharma Automates for Difficult-to-Convey Powder

Epic Pharma moved away from manually scooping cholestyramine resin into hoppers by installing four automated flexible screw conveyors from Flexicon Corporation.

When Will Adderall Shortage End? - Vimarsana News

When Will Adderall Shortage End?

The shortage was initially announced by the FDA in mid-October.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2023 Ended September 30, 2022 and Provides Conference Call Information - Vimarsana News

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2023 Ended September 30, 2022 and Provides Conference Call Information

Conference Call Scheduled for Tuesday, November 15 at 11:30 AM ESTNORTHVALE, NJ / ACCESSWIRE / November 15, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical

Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study - Vimarsana News

Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study

Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence StudyNORTHVALE, NJ / ACCESSWIRE / November 2, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a

Stark graph shows how Adderall prescriptions DOUBLED during pandemic - Vimarsana News

Stark graph shows how Adderall prescriptions DOUBLED during pandemic

Prescriptions for Adderall more than doubled from the start of the COVID-19 pandemic until September 2022, a new report finds. The FDA reports that the drug is currently in a shortage.